IMMUNEONCO BIOPHARMA
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.
IMMUNEONCO BIOPHARMA
Industry:
Biopharma Biotechnology Health Care
Founded:
2015-06-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.immuneonco.com
Total Employee:
11+
Status:
Active
Contact:
+86-21-58356573
Total Funding:
147.21 M USD
Technology used in webpage:
SPF China Telecom Alibaba Cloud MailBox
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Current Employees Featured
Wenzhi Tian Chairman, Founder, and CEO @ ImmuneOnco Biopharma
Chairman, Founder, and CEO
2015-01-01
Founder
Investors List
Milestone
Milestone investment in Series C - ImmuneOnco Biopharma
Sunshine Insurance Group
Sunshine Insurance Group investment in Series C - ImmuneOnco Biopharma
CCB Trust
CCB Trust investment in Series C - ImmuneOnco Biopharma
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - ImmuneOnco Biopharma
Founder H Fund
Founder H Fund investment in Series C - ImmuneOnco Biopharma
CDF-Capital
CDF-Capital investment in Series C - ImmuneOnco Biopharma
CASH Capital
CASH Capital investment in Series C - ImmuneOnco Biopharma
Zhangke Lingyi Investment
Zhangke Lingyi Investment investment in Series C - ImmuneOnco Biopharma
Shanghai International Group (SIG)
Shanghai International Group (SIG) investment in Series C - ImmuneOnco Biopharma
LYFE Capital
LYFE Capital investment in Series C - ImmuneOnco Biopharma
Official Site Inspections
http://www.immuneonco.com Semrush global rank: 7.79 M Semrush visits lastest month: 437
- Host name: 121.199.6.220
- IP address: 121.199.6.220
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "ImmuneOnco Biopharma"
ImmuneOnco - 宜明昂科英文-宜明昂科英文
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. was established in the PRC in June 2015. ImmuneOnco is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. ImmuneOnco is one of the …See details»
ImmuneOnco Biopharma - Crunchbase Company …
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated …See details»
About Us-宜明昂科英文 - ImmuneOnco
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. was established in the PRC in June 2015. ImmuneOnco is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. ImmuneOnco is one of the …See details»
宜明昂科生物医药技术(上海)有限公司 | LinkedIn
Non-profit Organization Management ... ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd., founded in June 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an clinical-stage ...See details»
Corporate Presentation - cn.immuneonco.com
6 Management team 30 issued patents, 23 patent applications, and 30+ scientific publications Wenzhi Tian, MD, EMBA Founder, Chairman & CEO 30+ years academic and industrial …See details»
ImmuneOnco - Products, Competitors, Financials, Employees, …
ImmuneOnco (1541.HK) is an early-stage biopharmaceutical company that focuses on the development and commercialization of novel cancer immunotherapy products designed to …See details»
ImmuneOnco Biopharma - Funding, Financials, Valuation & Investors
ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products. New. Resources. Advanced Search. ... How much …See details»
ImmuneOnco Biopharma - Org Chart, Teams, Culture & Jobs - The …
View ImmuneOnco Biopharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
ImmuneOnco Biopharma Co., Ltd - VentureRadar
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is a clinical-stage;biopharmaceutical company dedicated to development and …See details»
ImmuneOnco Biopharma - Craft
ImmuneOnco Biopharma (宜明昂科生物医药技术) is a biopharmaceutical company dedicated to the development and commercialization of cancer immunotherapy products. It aims to reverse …See details»
ImmuneOnco - Overview, News & Similar companies
Who is ImmuneOnco. Founded in June 2015, ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. is registered in Zhangjiang High Tech Park, Shanghai. The company is mainl y engaged …See details»
ImmuneOnco Biopharmaceuticals Inc - BIO CEO & Investor …
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... ImmuneOnco …See details»
ImmuneOnco Biopharma - Contacts, Employees, Board Members, …
Organization. ImmuneOnco Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Environmental, Social and Governance Report - cn.immuneonco.com
ImmuneOnco Biopharmaceuticals (Shanghai) Inc., established in the PRC in June 2015, is a science-driven biotechnology ... Name of Honor/Qualification Awarding organization The 2nd …See details»
ImmuneOnco 2025 Company Profile: Stock Performance
ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few …See details»
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. - Drug pipelines ...
Mar 7, 2025 ImmuneOnco announced it plans to enroll first-line patients in this trial and anticipates presenting initial clinical data, including data for first-line NSCLC patients, from this …See details»
IMMUNEONCO-B (1541.HK) Company Profile & Facts - Yahoo …
See the company profile for IMMUNEONCO-B (1541.HK) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
ImmuneOnco Biopharmaceuticals – HK$319 Million IPO - Cooley
Hong Kong – September 5, 2023 – Cooley advised ImmuneOnco Biopharmaceuticals, a clinical-stage biotechnology company dedicated to the development of immuno-oncology therapies, …See details»
ImmuneOnco axes CD47 bispecific amid pipeline prioritization
3 days ago ImmuneOnco received clearance to test IMM2520 in humans in China and the U.S. late in 2022. A study started in China in March 2023 and had enrolled 26 solid tumor patients …See details»
Shanghai ImmuneOnco Raises $89 Million for Cancer …
Mar 25, 2021 Shanghai ImmuneOnco Biopharma completed an $89 million Series C funding led by Guangdong's Greater Homeland Bay Area Investments and Lilly Asia Ventures. Founded in …See details»